Determination of the optimal sample size for a clinical trial accounting for the population size

Biometrical Journal

Volumn 59, Issue 4, 2017, Pages 609-625

  Stallard, Nigel ^a   Miller, Frank ^b   Day, Simon ^c   Hee, Siew Wan ^a   Madan, Jason ^a   Zohar, Sarah ^d   Posch, Martin ^e  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c Clinical Trials Consulting and Training Limited   (United Kingdom)

^d INSERM   (France)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bayesian; Clinical trial design; Decision theory; Exponential family form; Optimal sample size

Indexed keywords

DECISION THEORY; MEDICAL APPLICATIONS; POPULATION STATISTICS; SAMPLING;

ASYMPTOTIC EXPRESSIONS; BAYESIAN; CLINICAL TRIAL; CLINICAL TRIAL DESIGNS; EXPONENTIAL FAMILY; EXPONENTIAL FAMILY FORM; OPTIMAL SAMPLE SIZE; OPTIMAL SAMPLES; POPULATION SIZES; SAMPLE SIZES;

POISSON DISTRIBUTION;

BAYES THEOREM; CLINICAL TRIAL (TOPIC); HUMAN; POISSON DISTRIBUTION; POPULATION DENSITY; PROCEDURES; SAMPLE SIZE;

BAYES THEOREM; CLINICAL TRIALS AS TOPIC; HUMANS; POISSON DISTRIBUTION; POPULATION DENSITY; SAMPLE SIZE;

EID: 84969941193     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.201500228     Document Type: Article

References (20)

1. Anscombe, F. J. (1963). Sequential medical trials. Journal of the American Statistical Association 58, 365–383.
2. Bernado, J. M. and Smith, A. F. M. (2000). Bayesian Theory, Wiley, Chichester, UK.
3. Berry, D. A. and Fristedt, B. (1985). Bandit Problems: Sequential Allocation of Experiments. Chapman and Hall, London, UK.
4. Berry, D. A., Wolff, M. C. and Sack, D. (1994). Decision-making during a phase III randomized controlled trial. Controlled Clinical Trials 15, 360–378.
5. Cheng, Y., Fusheng, S. and Berry, D. A. (2003). Choosing sample size for a clinical trial using decision analysis. Biometrika 90, 923–936.
6. Clark, C. E. (1961). The greatest of a finite set of random variables. Operations Research 9, 145–162.
7. Colton, T. (1963). A model for selecting one of two medical treatments. Journal of the American Statistical Association 58, 388–400.
8. Fergusson, T. S. (2008). Optimal Stopping and Applications. UCLA, Los Angeles, CA.
9. Fleming, T. R. (1982). One-sample multiple testing procedure for phase II clinical trial. Biometrics 38, 143–151.
10. Hee, S. W., Hamborg, T., Day, S., Madan, J., Miller, F., Posch, M., Zohar, S. and Stallard, N. (2016). Decision theoretic designs for small trials and pilot studies: a review. Statistical Methods in Medical Research. DOI: 10.1177/0962280215588245
11. Kikuchi, T. and Gittins, J. (2009). A behavioral Bayes method to determine the sample size of a clinical trial considering efficacy and safety. Statistics in Medicine 28, 2293–2306.
12. Lindley, D. V. (1997). The choice of sample size. Journal of the Royal Statistical Society, Series D 46, 129–138.
13. Pezeshk, H., Nematollahi, N., Maroufy, V., Marriott, P. and Gittins, J. (2013). Bayesian sample size calculation for estimation of the difference between two binomial proportions. Statistical Methods in Medical Research 22, 598–611.
14. Pocock, S. J. (1983). Clinical Trials: A Practical Approach. Wiley, Chichester, UK.
15. Posch, M. and Bauer, P. (2013). Adaptive budgets in clinical trials. Statistics in Biopharmaceutical Research 5, 282–292.
16. Raiffa, H. and Schlaifer, R. (1961). Applied Statistical Decision Theory. Harvard University Graduate School of Business Administration.
17. Schoenfeld, D. (1980). Statistical considerations for pilot studies. International Journal of Radiation Oncology Biology Physics 6, 371–374.
18. Stallard, N. (1998). Sample size determination for phase II clinical trials based on Bayesian decision theory. Biometrics 54, 279–294.
19. Stallard, N. (2012). Optimal sample sizes for phase II clinical trials and pilot studies. Statistics in Medicine 31, 1031–1042.
20. Sylvester, R. J. (1988). A Bayesian approach to the design of phase II clinical trials. Biometrics 44, 823–836.